Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Accretion Nutraveda Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Accretion Nutraveda Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Accretion Nutraveda - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    15 May 2026, 6:59PM Accretion Nutraveda Limited has informed the Exchange regarding Press Release dated 15th May, 2026, titled \Company Delivers Robust Performance in H2
  • Accretion Nutraveda - Appointment Of Internal Auditors

    8 May 2026, 7:54PM Please find enclosed herewith Intimation with respect to Appointment Internal Auditor of the company.
  • Accretion Nutraveda - Appointment Of Secretarial Auditors

    8 May 2026, 7:47PM Please find enclosed herewith intimation with respect to Appointment of Secretarial Auditor of the Company.
  • Accretion Nutraveda - Announcement under Regulation 30 (LODR)-Change in Management

    8 May 2026, 7:41PM Please find enclosed herewith Appointment of Ms. Grishma A Shewale as an Additional Non - Executive Independent Director of the Company.
  • Accretion Nutraveda - Announcement under Regulation 30 (LODR)-Change in Management

    8 May 2026, 7:36PM Please find enclosed herewith Appointment of Mr. Chand Rameshbhai Kanabar as an Additional Non- Executive Independent Director of the Company.
  • Accretion Nutraveda - Announcement under Regulation 30 (LODR)-Resignation of Director

    8 May 2026, 7:09PM Please find enclosed herewith resignation of Mr. Mahipal singh chouhan as non-Executive Independent Director of the Company.
  • Accretion Nutraveda - Announcement under Regulation 30 (LODR)-Resignation of Director

    8 May 2026, 7:01PM Please Find Enclosed herewith Resignation of Mr. Arun Dash as Non - Executive Independent Director
  • Accretion Nutraveda - Board Meeting Outcome for Outcome Of Board Meeting Financial Results 31St March 2026

    8 May 2026, 6:53PM Please find enclosed herewith Outcome of Board Meeting dated 08th May, 2026
  • Accretion Nutraveda - Board Meeting Intimation for Board Meeting Intimation For Consider And Approve Audited Financial Result

    1 May 2026, 7:55PM Accretion Nutraveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider
  • Accretion Nutraveda - Clarification On Price Movement

    30 Apr 2026, 1:02PM Please find enclosed herewith clarification Letter on price movement
  • Accretion Nutraveda - Clarification sought from Accretion Nutraveda Ltd

    29 Apr 2026, 6:48PM The Exchange has sought clarification from Accretion Nutraveda Ltd on April 29, 2026 with reference to significant movement in price, in order to ens
  • Accretion Nutraveda - Confirmation Regarding Non-Applicability Of Large Corporate Disclosure Requirements

    29 Apr 2026, 4:51PM Please find enclosed herewith confirmation regarding Non-Applicability of Large Corporate disclosure requirements
  • Accretion Nutraveda has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    18 Apr 2026, 5:10PM As of March 2026, 73.48% is owned by Indian Promoters and 26.52% by Public. <p align=justify> Top five Promoters holding highest number of shares of A
  • Accretion Nutraveda - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Apr 2026, 5:26PM Please find enclosed herewith intimation under regulation 74(5) of SEBI (DP) Regulations, 2018
  • Accretion Nutraveda - Intimation For Change Of Corporate Identification Number (CIN) Of The Company.

    1 Apr 2026, 2:28PM Pursuant to the listing of Equity share of the Company, the Corporate Identification Number (CIN) in the Master Data as available on the Ministry of
  • Accretion Nutraveda - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulat

    26 Mar 2026, 3:37PM Please find enclosed herewith intimation under regulation 30(5) of The SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Accretion Nutraveda - Appointment Of Internal Auditors

    26 Mar 2026, 3:33PM Please find enclosed herewith intimation with respect to appointment of Internal Auditor of the Company.
  • Accretion Nutraveda - Board Meeting Outcome for Outcome Of The Board Meeting

    26 Mar 2026, 3:26PM Please find enclosed herewith outcome of the Board Meeting
  • Accretion Nutraveda - Clarification On Price Movement

    20 Feb 2026, 4:46PM Please find enclosed herewith clarification letter on Price Movement
  • Accretion Nutraveda - Clarification sought from Accretion Nutraveda Ltd

    19 Feb 2026, 7:00PM The Exchange has sought clarification from Accretion Nutraveda Ltd on February 19, 2026 with reference to significant movement in price, in order to e

Key fundamentals

Evaluate the intrinsic value of Accretion Nutraveda Ltd stock 

Name March-26 March-25 March-24 March-23
Assets 39.7015 9.2074 3.2585 2.2364
Liabilities 39.7015 9.2074 3.2585 2.2364
Equity 7.24 0.487 0.36 0.36
Gross Profit 6.8934 3.7231 1.2241 0.6215
Net Profit 5.0683 2.6128 0.8219 0.2806
Cash From Operating Activities -23.9246 -2.2128 0.2302 0.6813
NPM(%) 15.08 16.32 16.42 9.66
Revenue 33.6031 16.0018 5.0052 2.9031
Expenses 26.7097 12.2787 3.7811 2.2816
ROE(%) 49.75 25.64 8.06 2.75

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Accretion Nutraveda Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 707.60 -2.19 0.00 155.24 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 104.00 -2.80 337.87 565.66 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 17.58 1.15 0.00 1174.50 -39.50 0.00
Astec Lifesciences Ltd 744.05 9.92 0.00 533.43 -363.15 0.00

Company Info

Our Company was originally incorporated as a Private limited company in the name of "Accretion Nutraveda Private Limited" on March 16, 2021, pursuant to the provisions of the Companies Act, 2013, and was granted a certificate of incorporation dated March 16, 2021, by the Registrar of Companies, Central Registration Centre, Ahmedabad. Pursuant to a special resolution passed by our Shareholders in the Extra-Ordinary General Meeting held on April 12, 2025 our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed to "Accretion Nutraveda Limited" and a fresh certificate of incorporation dated May 02, 2025 was issued to our Company by the Registrar of Companies, Central Processing Centre, Ahmedabad. The present CIN of our Company is U24290GJ2021PLC121216. For information on our Company's profile, activities, market, service, etc., market of each segment, standing of our Company in comparison with prominent competitors, with reference to its services, management, managerial competence, technology, market, major suppliers and customers, environmental issues, geographical segment, etc.MAJOR EVENTS AND MILESTONES:2022- The Company was incorporated as a Private Limited Company.2023- The Company entered into a lease deed for a period of 10 (ten) years.2025- The Company was converted from a Private Limited Company into a Public Limited Company.- The Company entered into a lease deed for a period of 10 (ten) years for the proposed manufacturing unit.

Our Company was originally incorporated as a Private limited company in the name of "Accretion Nutraveda Private Limited" on March 16, 2021, pursuant to the provisions of the Companies Act, 2013, and was granted a certificate of incorporation dated March 16, 2021, by the Registrar of Companies, Central Registration Centre, Ahmedabad. Pursuant to a special resolution passed by our Shareholders in the Extra-Ordinary General Meeting held on April 12, 2025 our Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed to "Accretion Nutraveda Limited" and a fresh certificate of incorporation dated May 02, 2025 was issued to our Company by the Registrar of Companies, Central Processing Centre, Ahmedabad. The present CIN of our Company is U24290GJ2021PLC121216. For information on our Company's profile, activities, market, service, etc., market of each segment, standing of our Company in comparison with prominent competitors, with reference to its services, management, managerial competence, technology, market, major suppliers and customers, environmental issues, geographical segment, etc.MAJOR EVENTS AND MILESTONES:2022- The Company was incorporated as a Private Limited Company.2023- The Company entered into a lease deed for a period of 10 (ten) years.2025- The Company was converted from a Private Limited Company into a Public Limited Company.- The Company entered into a lease deed for a period of 10 (ten) years for the proposed manufacturing unit.

Read More

Parent Organisation

Accretion Nutraveda Ltd.

Founded

16/03/2021

Managing Director

Mr.Mayur Popatlal Sojitra

NSE Symbol

FAQ

The current price of Accretion Nutraveda Ltd is

The 52-week high for Accretion Nutraveda Ltd is

The market capitalization of Accretion Nutraveda Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Accretion Nutraveda Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Accretion Nutraveda Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Accretion Nutraveda Ltd shares.

The CEO of Accretion Nutraveda Ltd is Mr.Mayur Popatlal Sojitra, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT